Incyte Corp. (INCY)

Index:

Nasdaq 100

$ 64.51
   
  • Change Today:
    $-0.27
  • 52 Week High: $83.38
  • 52 Week Low: $55.11
  • Currency: US Dollars
  • Shares Issued: 193.43m
  • Volume: 1,557,150
  • Market Cap: $12,478m
  • RiskGrade: 196

Latest ShareCast News

FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir

By Alexander Bueso

Date: Friday 20 Nov 2020

(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Incyte Corp. Market Data

Currency US Dollars
Share Price $ 64.51
Change Today $ -0.27
% Change -0.42 %
52 Week High $83.38
52 Week Low $55.11
Volume 1,557,150
Shares Issued 193.43m
Market Cap $12,478m
RiskGrade 196

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 13
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-May-2025

Time Volume / Share Price
16:00 218,699 @ $64.51
15:59 133 @ $64.49
15:59 100 @ $64.50
15:59 100 @ $64.48
15:59 800 @ $64.51

Top of Page